Material basis and molecular mechanism of Angelicae Sinensis Radix in activating blood:based on computer-aided drug design.
10.19540/j.cnki.cjcmm.20211117.704
- Author:
Jia LIN
1
;
Juan YAO
1
;
Min ZHANG
1
;
Chao-Xin LI
2
;
Ya-Ling LI
3
;
Lu QIU
3
;
Ye-Hu HOU
3
;
Yong-Qi LIU
4
;
Xiao-Jie JIN
5
Author Information
1. College of Pharmacy,Gansu University of Chinese Medicine Lanzhou 730000,China Northwest Collaborative Innovation Center for Chinese Medicine Lanzhou 730000,China.
2. College of Pharmacy,Gansu University of Chinese Medicine Lanzhou 730000,China.
3. Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases,Gansu University of Chinese Medicine Lanzhou 730000,China.
4. Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases,Gansu University of Chinese Medicine Lanzhou 730000,China Key Laboratory of Dunhuang Medicine and Transformation,Ministry of Education,Gansu University of Chinese Medicine Lanzhou 730000,China.
5. College of Pharmacy,Gansu University of Chinese Medicine Lanzhou 730000,China Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases,Gansu University of Chinese Medicine Lanzhou 730000,China.
- Publication Type:Journal Article
- Keywords:
ADMET;
Angelicae Sinensis Radix;
FXa;
THR;
activating blood;
complex network analysis;
computer-aided drug design
- MeSH:
Anticoagulants/pharmacology*;
Blood Coagulation;
Drug Design;
Drugs, Chinese Herbal/pharmacology*;
Molecular Docking Simulation
- From:
China Journal of Chinese Materia Medica
2022;47(7):1942-1954
- CountryChina
- Language:Chinese
-
Abstract:
Angelicae Sinensis Radix excels in activating blood, but the scientific mechanism has not been systematically analyzed, thus limiting the development of the medicinal. This study employed the computer-aided drug design methods, such as structural similarity-based target reverse prediction, complex network analysis, molecular docking, binding free energy calculation, cluster analysis, and ADMET(absorption, distribution, metabolism, excretion, toxicity) calculation, and enzyme activity assay in vitro, to explore the components and mechanism of Angelicae Sinensis Radix in activating blood. Target reverse prediction and complex network analysis yielded 40 potential anticoagulant targets of the medicinal. Gene Ontology(GO) term enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analysis indicated that the targets mainly acted on the complement and coagulation cascade signaling pathway to exert the anticoagulant function. Among them, the key enzymes thrombin(THR) and coagulation factor Xa(FXa) in coagulation cascade and thrombosis were the drug targets for thromboembolic diseases. At the same time, molecular docking and cluster analysis showed that the medicinal had high selectivity for FXa. According to binding free energy score, 8 potential active components were selected for enzyme activity assay in vitro. The results demonstrated that 8 components inhibited THR and FXa, and the inhibition was stronger on FXa than on THR. The pharmacophore model of 8 active compounds was constructed, which suggested that the components had the common pharmacophore AAHH. The ADMET calculation result indicated that they had good pharmacokinetic properties and were safe. Based on target reverse prediction, complex network analysis, molecular docking and binding free energy calculation, anticoagulant activity in vitro, spatial binding conformation of molecules and targets, pharmacophore model construction, and ADMET calculation, this study preliminarily clarified the material basis and molecular mechanism of Angelicae Sinensis Radix in activating blood from the perspective of big data, and calculated the pharmacology and toxicology parameters of the active components. Our study, for the first time, revealed that the medicinal had obvious selectivity and pertinence for different coagulation proteins, reflecting the unique effect of different Chinese medicinals and the biological basis. Therefore, this study can provide clues for precision application of Angelicae Sinensis Radix and the development of the blood-activating components with modern technology.
